Literature DB >> 8140075

Erythromelalgic, thrombotic and haemorrhagic manifestations of thrombocythaemia.

P J van Genderen1, J J Michiels.   

Abstract

OBJECTIVES: In order to document a relationship between platelet counts and clinical complication of thrombosis or bleeding in patients with myeloproliferative thrombocythaemia, 200 consecutive published cases of thrombocythaemia were reviewed for thrombotic or haemorrhagic manifestations and haematological findings at the time of the thrombohaemorrhagic complication.
METHODS: Cases selected from the literature included all those complying with the diagnosis of thrombocythaemia as mandated by the Polycythemia Vera Study Group. One hundred consecutive cases of thrombocythaemia complicated by bleedings and one hundred consecutive cases of thrombocythaemia complicated by thrombosis were reviewed for clinical manifestations and haematological findings.
RESULTS: In the reviewed cases of thrombocythaemia haemorrhagic complications (platelet count 2016 +/- 1070 x 10(9)/1) occurred at significantly (p < 0.001) higher degrees of thrombocytosis than thrombotic complications (platelet count 1110 +/- 477 x 10(9)/1).
CONCLUSIONS: In the reviewed cases of thrombocythaemia arterial complications, especially erythromelalgia, can already be documented at platelet counts in excess of 400 x 10(9)/1, whereas bleeding complications usually occur at significantly higher degrees of thrombocytosis (> 1000 x 10(9)/1).

Entities:  

Mesh:

Year:  1994        PMID: 8140075

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  7 in total

Review 1.  Management of myeloproliferative neoplasms: from academic guidelines to clinical practice.

Authors:  Giovanni Barosi; Letizia Lupo; Vittorio Rosti
Journal:  Curr Hematol Malig Rep       Date:  2012-03       Impact factor: 3.952

2.  Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: relationship with platelet count.

Authors:  P J van Genderen; J J Michiels; S C van der Poel-van de Luytgaarde; H H van Vliet
Journal:  Ann Hematol       Date:  1994-08       Impact factor: 3.673

Review 3.  Acquired von Willebrand syndrome: its pathophysiology, laboratory features and management.

Authors:  Hiroshi Mohri
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

Review 4.  Myeloproliferative and thrombotic burden and treatment outcome of thrombocythemia and polycythemia patients.

Authors:  Jan Jacques Michiels
Journal:  World J Crit Care Med       Date:  2015-08-04

5.  Bleeding complications in BCR-ABL negative myeloproliferative neoplasms: prevalence, type, and risk factors in a single-center cohort.

Authors:  Elizabeth M Kander; Sania Raza; Zheng Zhou; Juehua Gao; Anaadriana Zakarija; Brandon J McMahon; Brady L Stein
Journal:  Int J Hematol       Date:  2015-10-06       Impact factor: 2.490

6.  Development of Alveolar Hemorrhage in a Patient with Acute Myocardial Infarction Complicated with Essential Thrombocythemia.

Authors:  Masahiro Ishikura; Akihiro Endo; Kaito Koshino; Yuzo Kagawa; Kazuaki Tanabe
Journal:  Am J Case Rep       Date:  2021-02-09

Review 7.  Acute compartment syndrome as the initial manifestation of chronic-phase chronic myeloid leukemia: a case report and review of the literature.

Authors:  Yoshikazu Nagase; Shuji Ueda; Hitomi Matsunaga; Aya Yoshioka; Yoshiyuki Okada; Tomohisa Machida; Keiichi Nakata; Fuka Mima; Risato Takeda; Daisuke Hayashi; Sadaharu Iio; Kohei Okita; Hiroyuki Narahara; Yuichi Yasunaga; Yoshiaki Inui; Sumio Kawata
Journal:  J Med Case Rep       Date:  2016-07-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.